FindTrial
Sign In

Therapeutic Plasma exchange practices in intensive care unit

A study to describe indications,practices,outcome of therapeutic plasma exchange in tertiary care ICU - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100807
Enrollment
200
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M95- Other acquired deformities of musculoskeletal system and connective tissue

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

S Priyadharshan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients who underwent therapeutic plasma exchange in Apollo Main Hospital between 2021 to 2024.

Exclusion criteria

Exclusion criteria: patients who are not underwent plasma exchange.

Design outcomes

Primary

MeasureTime frame
Events during procedure (hypotension, tachycardia,desaturation- New oxygen requirement,itching,Reason for stoppage of session)Timepoint: baseline—

Secondary

MeasureTime frame
Hospital Outcome - favorable /Disease remission Duration of hospital stay Duration of ICU stay Duration of mechanical ventilation In-hospital mortality Other immunomodulatory therapiesTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactBalaji Rajaraman

Department of critical care medicine, Apollo Main Hospital

balajirajaram@icuconsultants.com8098010637

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026